Anne‐Sophie Carret
Pfizer (United States)(US)Menarini Group (Italy)(IT)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients(2000)376 cited
- → Treatment of Adenovirus Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation(2001)262 cited
- → Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer(2022)250 cited
- → Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience(2011)213 cited
- → Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer(2023)162 cited
- → Remote control of the permeability of the blood–brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery(2015)149 cited